Showing 1 - 7 results of 7 for search 'Peter E. Lobie', query time: 0.03s Refine Results
  1. 1
    Reply to: “The non-cytotoxic small molecule NPB does not inhibit BAD phosphorylation and forms colloidal aggregates”

    Reply to: “The non-cytotoxic small molecule NPB does not inhibit BAD phosphorylation and forms colloidal aggregates” by Xi Zhang, Basappa Basappa, Peter E. Lobie, Vijay Pandey

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    XIAP 3′-untranslated region serves as a competitor for HMGA2 by arresting endogenous let-7a-5p in human hepatocellular carcinoma

    XIAP 3′-untranslated region serves as a competitor for HMGA2 by arresting endogenous let-7a-5p in human hepatocellular carcinoma by Wen-Yong Wu, Si-Qi Tao, Xiao-Nan Wang, Peter E Lobie, Zheng-Sheng Wu

    Published 2017-07-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Inhibition of TFF3 synergizes with c-MET inhibitors to decrease the CSC-like phenotype and metastatic burden in ER+HER2+ mammary carcinoma

    Inhibition of TFF3 synergizes with c-MET inhibitors to decrease the CSC-like phenotype and metastatic burden in ER+HER2+ mammary carcinoma by Chuyu He, Xuejuan Wang, Yi-Shiou Chiou, Basappa Basappa, Tao Zhu, Vijay Pandey, Peter E. Lobie

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Microdroplet-Engineered Skeletal Muscle Organoids from Primary Tissue Recapitulate Parental Physiology with High Reproducibility

    Microdroplet-Engineered Skeletal Muscle Organoids from Primary Tissue Recapitulate Parental Physiology with High Reproducibility by Jiawei Li, Yiming Yang, Ziqi Yi, Yu Zhu, Haowei Yang, Baiming Chen, Peter E. Lobie, Shaohua Ma

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Estrogen-induced FXR1 promotes endocrine resistance and bone metastasis in breast cancer via BCL2 and GPX4

    Estrogen-induced FXR1 promotes endocrine resistance and bone metastasis in breast cancer via BCL2 and GPX4 by Yinzhong Shang, Yinzhong Shang, Tingfang Cao, Xin Ma, Le Huang, Mingming Wu, Junchao Xu, Junchao Xu, Jiarui Wang, Hao Wang, Sheng Wu, Vijay Pandey, Zhengsheng Wu, Weijie Zhang, Weijie Zhang, Peter E. Lobie, Peter E. Lobie, Xinghua Han, Tao Zhu, Tao Zhu, Tao Zhu, Tao Zhu

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Discovery of 2‑Pyrazolines That Inhibit the Phosphorylation of STAT3 as Nanomolar Cytotoxic Agents

    Discovery of 2‑Pyrazolines That Inhibit the Phosphorylation of STAT3 as Nanomolar Cytotoxic Agents by Tejaswini P. Siddappa, Akshay Ravish, Zhang Xi, Arunkumar Mohan, Swamy S. Girimanchanaika, Niranjan Pattehali Krishnamurthy, Shreeja Basappa, Santosh L. Gaonkar, Peter E. Lobie, Vijay Pandey, Basappa Basappa

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    A novel drug prejudice scaffold-imidazopyridine-conjugate can promote cell death in a colorectal cancer model by binding to β-catenin and suppressing the Wnt signaling pathway

    A novel drug prejudice scaffold-imidazopyridine-conjugate can promote cell death in a colorectal cancer model by binding to β-catenin and suppressing the Wnt signaling pathway by Min Hee Yang, Basappa Basappa, Suresha N. Deveshegowda, Akshay Ravish, Arunkumar Mohan, Omantheswara Nagaraja, Mahendra Madegowda, Kanchugarakoppal S. Rangappa, Amudha Deivasigamani, Vijay Pandey, Peter E. Lobie, Kam Man Hui, Gautam Sethi, Kwang Seok Ahn

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: